Back
Zevra Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.58
Seasonality Move:
-1.31%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Zevra Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.25 | Buy |
| 20-day SMA: | 8.43 | Sell |
| 50-day SMA: | 9.47 | Sell |
| 200-day SMA: | 9.13 | Sell |
| 8-day EMA: | 4.34 | Buy |
| 20-day EMA: | 2.12 | Buy |
| 50-day EMA: | 0.92 | Buy |
| 200-day EMA: | 0.24 | Buy |
Zevra Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.54 | Buy |
| Relative Strength Index (14 RSI): | 41.81 | Sell |
| Chaikin Money Flow: | 468376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.18 - 9.02) | Sell |
| Bollinger Bands (100): | (8.28 - 10.64) | Sell |
Zevra Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics, Inc. Stock
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.31 while ZVRA 8-day simple moving average is 8.25, which is a Buy signal.
-
The stock price of ZVRA is 8.31 while Zevra Therapeutics, Inc. 20-day SMA is 8.43, which makes it a Sell.
-
Zevra Therapeutics, Inc. 50-day simple moving average is 9.47 while ZVRA share price is 8.31, making it a Sell technically.
-
ZVRA stock price is 8.31 and Zevra Therapeutics, Inc. 200-day simple moving average is 9.13, creating a Sell signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. a Buy or a Sell?
-
Zevra Therapeutics, Inc. stock is rated a SellThe current Zevra Therapeutics, Inc. [ZVRA] share price is $8.31. The Score for ZVRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics, Inc. Stock Info
Market Cap:
467.8M
Price in USD:
8.31
Share Volume:
869.8K
Zevra Therapeutics, Inc. 52-Week Range
52-Week High:
13.16
52-Week Low:
6.19
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Zevra Therapeutics, Inc. Share Price Forecast
-
What is the Zevra Therapeutics, Inc. stock price today?The Zevra Therapeutics, Inc. stock price is 8.31 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics, Inc. is overvalued.
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.31 while ZVRA 8-day exponential moving average is 4.34, which is a Buy signal.
-
The stock price of ZVRA is 8.31 while Zevra Therapeutics, Inc. 20-day EMA is 2.12, which makes it a Buy.
-
Zevra Therapeutics, Inc. 50-day exponential moving average is 0.92 while ZVRA share price is 8.31, making it a Buy technically.
-
ZVRA stock price is 8.31 and Zevra Therapeutics, Inc. 200-day simple moving average is 0.24, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics, Inc.
Is Zevra Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.09 per share, and a decrease next year of $0.54 per share.
Technical Analysis of Zevra Therapeutics, Inc.
Should I short Zevra Therapeutics, Inc. stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 1.54, suggesting Zevra Therapeutics, Inc. is a Buy
-
Zevra Therapeutics, Inc. Relative Strength Index (RSI) is 41.81, which suggest Zevra Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Zevra Therapeutics, Inc. is (8.18 - 9.02), which suggest Zevra Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics, Inc. is (8.28 - 10.64), which suggest Zevra Therapeutics, Inc. is a Sell
* Zevra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.